Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences

Atypical antipsychotics (AAPs) are commonly prescribed medications to treat schizophrenia, bipolar disorders and other psychotic disorders. However, they might cause metabolic syndrome (MetS) in terms of weight gain, dyslipidemia, type 2 diabetes (T2D), and high blood pressure, which are responsible...

Descripción completa

Detalles Bibliográficos
Autores principales: Carli, Marco, Kolachalam, Shivakumar, Longoni, Biancamaria, Pintaudi, Anna, Baldini, Marco, Aringhieri, Stefano, Fasciani, Irene, Annibale, Paolo, Maggio, Roberto, Scarselli, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001502/
https://www.ncbi.nlm.nih.gov/pubmed/33800403
http://dx.doi.org/10.3390/ph14030238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001502/
https://www.ncbi.nlm.nih.gov/pubmed/33800403
http://dx.doi.org/10.3390/ph14030238

Ejemplares similares